POST Online Media Lite Edition


Velocity Clinical Research strengthens management team amid European expansion

Christian Fernsby |
Durham, N.C., USA - Velocity Clinical Research, an integrated clinical trial site organisation, announces it has strengthened its management team as it embarks on European expansion.

Article continues below

Pharmaceutical industry heavyweights have joined the team, including Dominic Clavell, Executive Vice President, Europe, Erin Williams, Vice President, Contracts and Regulatory and Charles-Hubert Devaux, Senior Director, Patient Recruitment.

Members of the Velocity Clinical Research team.

Dominic Clavell joins Velocity to head up its European operations after a decorated career in some of the top clinical research organisations, site management organisations and pharmaceutical companies in the world, such as Parexel, IQVIA, Synexus and Novartis.

Velocity is simultaneously strengthening its senior management team in the US as the company prepares for its next stage of growth, following its sale to GHO Capital in April this year.

Erin Williams joins Velocity as Vice President of Regulatory and Site Contracting from Parexel, where she was Global Head of site contracting and was previously in the same role for PPD.

LATEST 5 MOVES FROM North Carolina 

What to read next

European Court of Justice supported Poland to limit Gazprom's use of OPAL
European Commission refers Bulgaria to Court of Justice for failure to connect its business register
European Guarantee Fund well over half its €24.4 bn target in first 6 months